Pharmacogenomics: How Our DNA Can Help Guide Safer and More Effective Cancer Treatments
Should two patients with the same type of cancer receive the same treatment? Discover Pharmacogenomics, a form of precision medicine that aims to improve the safety and effectiveness of cancer therapies by incorporating info about a patient's DNA into treatment decisions. Presented by Dr. Colin Ross, Investigator, BC Children's Hospital Research Institute; Assistant Professor, Faculty of Pharmaceutical Sciences, UBC; Associate Member, Department of Medical Genetics, UBC. (2019)
This week's Research Roundup covers babies' learning mechanisms that help them match unfamiliar voices to unfamiliar faces, the top risk factor that could signal greater disease severity in pediatric catecholaminergic polymorphic ventricular tachycardia, a virtual reality-based solution to reducing procedural anxiety in kids, and genetic testing for reducing diagnostic delay in monogenic inborn errors of immunity.
We believe there’s nothing we can’t do with your support. It can take years to turn scientific breakthrough into new interventions and treatments. Funding helps speed the pace of change. When given the resources, we can bring transformative therapies – and hope – out of the laboratory and into the clinic to save and improve children’s lives.